Peregrine Ventures — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Cordio Medical develops medical-grade digital health solutions that use speech signal processing algorithms to help patients monitor and manage their health, with a focus on cardiovascular and heart failure care.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Chaim Lotan(Executive Officer, Director)Ronit Haviv(Executive Officer)David Lifschitz(Director)Lior Shahori(Director)Ilan Shalom(Executive Officer)Leon Eting(Executive Officer)
Variantyx provides genetic testing services used to help diagnose rare conditions, guide cancer treatment, and inform pregnancy decisions for patients and their families.
BiotechDigital HealthHealthtechFramingham, US
Zafrira Avnur(Became a director following financing closing.)Noam Shomron(Was a director at financing closing.)Greg Faust(Director)Haim Neerman(Co-founder)Tomer Jackman(Co-founder & VP Customer Support and Lab Services)Jeffrey Weisberg(Chief Financial Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.